Quralis Corporation
Clinical trials sponsored by Quralis Corporation, explained in plain language.
-
New ALS drug QRL-201 enters human safety testing
Disease control OngoingThis early-stage study tests whether a new drug called QRL-201 is safe and tolerable for people with ALS (Lou Gehrig's disease). About 69 adults aged 18-80 with recent ALS symptoms will receive either the drug or a placebo. The main goal is to check for side effects, not to cure …
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Healthy volunteers needed to test safety of experimental drug QRL-101
Knowledge-focused OngoingThis early-stage study is testing a new drug, QRL-101, in healthy adults to see if it is safe and how the body processes it. About 48 participants will receive either the drug or a placebo. The goal is to gather safety information, not to treat any disease.
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC